首頁 > 市場調查報告書 > 材料/化學品

包裝/容器

市場調查報告書

商品編碼

2051079

軟膠囊市場：按產品類型、原料、應用、最終用戶和地區分類

Softgel Capsule Market, By Product Type, By Source Type, By Application, By End User, By Region

出版日期: 2026年03月12日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，軟膠囊市場規模將達到83.681億美元，2033年將達到130.896億美元。預計從2026年到2033年，其複合年成長率將達到6.6%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	83.681億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.60%	2033年市場規模預測：	130.896億美元

軟膠囊（也稱為軟膠囊）是一種由柔軟的明膠基材料製成的膠囊，內部填充液體或半固體填充物。這種填充材和明膠外殼相比傳統的硬膠囊具有許多優勢。由於軟膠囊的外殼比硬膠囊更薄、更柔軟性，消費者可以用更小的劑量攝取更多的活性成分。此外，明膠材料能夠加速外殼的溶解，使軟膠囊的吸收速度比硬膠囊更快。

軟膠囊主要分為兩大類。第一類由單層軟明膠殼構成，內含活性成分。第二類採用雙層結構，內層為密封層，防止內容物洩漏，外層為支撐層，確保結構強度。軟膠囊可包裹液體、半固體，甚至乾燥或糊狀填充物，拓展了硬膠囊無法實現的製劑應用範圍。然而，與硬膠囊相比，軟膠囊的生產需要專門的設備和技術，這可能導致更高的生產成本。此外，軟膠囊的明膠包衣穩定性不如硬膠囊包衣，更容易受到高溫、潮濕和不當儲存條件的影響。

市場動態

全球軟膠囊市場的主要驅動力是全球心血管疾病盛行率的不斷上升，導致軟膠囊的消費量和需求增加。動脈粥狀硬化和冠狀動脈疾病等多種心血管疾病是主要的醫療保健負擔，尤其是在人口老化和生活方式改變的已開發國家。心血管疾病已成為死亡和長期殘疾的主要原因之一。例如，根據美國疾病管制與預防中心（CDC）2023年5月15日發布的報告，心臟病是美國男性、女性以及大多數種族和族裔群體的主要死因，在美國，平均每33秒就有一人死於心血管疾病。

此外，根據加拿大公共衛生局 2022 年 11 月發布的報告，心臟病是加拿大第二大死因，每年奪走超過 5 萬人的生命。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球軟膠囊市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
這份全球軟膠囊市場報告旨在為行業內的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過用於分析全球軟膠囊市場的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

公司簡介
- Catalent, Inc.
- Aenova Group GmbH
- Sirio Pharma Company Ltd.
- Captek Softgel International Inc.
- Elnova Pharma
- Fuji Capsule Co., Ltd.
- Capsugel, EuroCaps Ltd.
- Guangdong Yichao Biological Co., Ltd.
- Hunan ER-KANG Pharmaceutical Co Ltd.
- KD Pharma Group
- United Laboratories
- Soft Gel Technologies, Inc.
- Windzor Pharma Ltd.
- ZYUS Life Sciences Inc.
- EuroCaps
分析師意見

第10章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI4265

Softgel Capsule Market is estimated to be valued at USD 8,368.1 Mn in 2026 and is expected to reach USD 13,089.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 8,368.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.60%	2033 Value Projection:	USD 13,089.6 Mn

Softgel capsules which is also known as softgels, are a type of capsule made of a soft, gelatin-based material that envelops a liquid or semi-solid fill. The fill material and gelatin shell offer different advantages over traditional hard capsules. Softgel shells are thinner and more flexible than hard capsules, thereby allowing more fill to be delivered in a smaller dosage form which is appreciated by consumers. The gelatin material also permits faster dissolution of the shell, thus making the fill available for absorption more quickly after ingestion compared to hard capsules.

There are two main types of softgel capsules. The first type is surrounded by a single soft gelatin shell which contains the active fill ingredient. The second type has a dual-layered construction with an inner sealing layer preventing leakage of the fill and an outer support layer providing structural integrity. Softgels are capable of holding liquid, semi-solid and even dry or paste-like fills which opens up formulation possibilities beyond what is offered by hard capsules. However, softgel manufacturing requires specialized equipment and expertise as compared to hard capsules which can increase production costs. Their gelatin-based shell is also less stable than hard capsule shells making them more vulnerable to heat, moisture and improper storage conditions.

Market Dynamics

Global softgel capsule market is mainly driven by the increasing prevalence of cardiovascular diseases across the world, thus leading to increasing consumption and demand of softgel capsules. Various cardiovascular diseases such as atherosclerosis, coronary artery diseases, and others have become major healthcare burdens, especially in developed nations with aging populations and lifestyle changes. As cardiac associations, cardiovascular diseases have emerged as the leading cause of mortality and long-term disabilities. For instance, on May 15, 2023, according to the report published by the Centers for Disease Control and Prevention, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the U.S., while one person dies every 33 seconds in the U.S. from cardiovascular disease.

Furthermore, in November 2022, according to the report published by the Public Health Agency in Canada, heart disease is the second leading cause of death in Canada, claiming more than 50,000 lives each year.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global softgel capsule market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Catalent, Inc., Aenova Group GmbH, Sirio Pharma Company Ltd, Captek Softgel International Inc., Elnova Pharma, Fuji Capsule Co., Ltd., Capsugel, EuroCaps Ltd, Guangdong Yichao Biological Co., Ltd., Hunan ER-KANG Pharmaceutical Co Ltd, KD Pharma Group, United Laboratories, Soft Gel Technologies, Inc., Windzor Pharma Ltd , ZYUS Life Sciences Inc. and EuroCaps.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global softgel capsule market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global softgel capsule market.

Market Segmentation

By Product Type (Revenue, USD Mn, 2021 - 2033)
Gelatin Softgel Capsule
Non-gelatin Softgel Capsule
By Source Type (Revenue, USD Mn, 2021 - 2033)
Animal-based
Non-animal-based
By Application (Revenue, USD Mn, 2021 - 2033)
Anti-inflammatory Drugs
Antibiotic Drugs
Cardiovascular Drugs
Health Supplements
Others
By End User (Revenue, USD Mn, 2021 - 2033)
Pharmaceutical Companies
Contract Manufacturing Organizations
Neutraceuticals Companies
Others
By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top Companies in Global Softgel Capsule Market
Catalent, Inc.
Aenova Group GmbH
Sirio Pharma Company Ltd.
Captek Softgel International Inc.
Elnova Pharma
Fuji Capsule Co., Ltd.
Capsugel, EuroCaps Ltd.
Guangdong Yichao Biological Co., Ltd.
Hunan ER-KANG Pharmaceutical Co Ltd.
KD Pharma Group
United Laboratories
Soft Gel Technologies, Inc.
Windzor Pharma Ltd.
ZYUS Life Sciences Inc.
EuroCaps

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Softgel Capsule Market, By Product Type
- Global Softgel Capsule Market, By Source Type
- Global Softgel Capsule Market, By Application
- Global Softgel Capsule Market, By End User
- Global Softgel Capsule Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rising global nutraceuticals industry
- High production cost associated with softgel capsules
- Emerging markets in Asia Pacific and Latin America
Key Highlights
Regulatory Scenario
Recent Trends
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Softgel Capsule Market, By Product Type, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Gelatin Softgel Capsule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Non-gelatin Softgel Capsule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

5. Global Softgel Capsule Market, By Source Type, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Animal-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Non-animal-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

6. Global Softgel Capsule Market, By Application, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Antibiotic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Cardiovascular Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Health Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

7. Global Softgel Capsule Market, By End User, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Contract Manufacturing Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Neutraceuticals Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

8. Global Softgel Capsule Market, By Region, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profile
- Catalent, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Aenova Group GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sirio Pharma Company Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Captek Softgel International Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Elnova Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Fuji Capsule Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Capsugel, EuroCaps Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Guangdong Yichao Biological Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Hunan ER-KANG Pharmaceutical Co Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- KD Pharma Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- United Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Soft Gel Technologies, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Windzor Pharma Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- ZYUS Life Sciences Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- EuroCaps
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Analyst Views